• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类黄病毒疫苗的最新进展。

Recent advances in human flavivirus vaccines.

作者信息

Scherwitzl Iris, Mongkolsapaja Juthathip, Screaton Gavin

机构信息

Department of Medicine, Imperial College London, W12 0NN London, UK.

Department of Medicine, Imperial College London, W12 0NN London, UK; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

出版信息

Curr Opin Virol. 2017 Apr;23:95-101. doi: 10.1016/j.coviro.2017.04.002. Epub 2017 May 6.

DOI:10.1016/j.coviro.2017.04.002
PMID:28486135
Abstract

Dengue (DENV), West Nile (WNV) and Zika (ZIKV) viruses are mosquito-transmitted flaviviruses that cause thousands of human deaths and millions of illnesses each year. In the last decades, epidemic outbreaks of all three flaviviruses emerged and caused a major health and economical problem in many parts of the world. The increasing and expanding burden of flaviviruses has highlighted the need for effective human vaccines against all three viruses. This review provides an overview of the recent progress in DENV, WNV and ZIKV vaccines development with specific focus on candidates in human clinical development.

摘要

登革热病毒(DENV)、西尼罗河病毒(WNV)和寨卡病毒(ZIKV)是通过蚊子传播的黄病毒,每年导致数千人死亡,数百万人患病。在过去几十年中,这三种黄病毒都出现了疫情爆发,在世界许多地区造成了重大的健康和经济问题。黄病毒日益加重且不断扩大的负担凸显了研发针对这三种病毒的有效人类疫苗的必要性。本综述概述了登革热病毒、西尼罗河病毒和寨卡病毒疫苗研发的最新进展,特别关注处于人体临床开发阶段的候选疫苗。

相似文献

1
Recent advances in human flavivirus vaccines.人类黄病毒疫苗的最新进展。
Curr Opin Virol. 2017 Apr;23:95-101. doi: 10.1016/j.coviro.2017.04.002. Epub 2017 May 6.
2
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
3
T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.减毒黄病毒疫苗诱导的 T 细胞反应具有特异性,与其他黄病毒种属表现出有限的交叉反应性。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00089-20.
4
Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa.西非塞内加尔登革热、寨卡病毒、黄热病和西尼罗河病毒的血清阳性率
J Med Virol. 2025 Apr;97(4):e70338. doi: 10.1002/jmv.70338.
5
Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.登革热和 Zika 病毒的交叉反应性 T 细胞免疫:疫苗开发的新见解。
Front Immunol. 2019 Jun 11;10:1316. doi: 10.3389/fimmu.2019.01316. eCollection 2019.
6
Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.鉴定抗前膜抗体作为血清复合物特异性标志物以区分寨卡病毒、登革热病毒和西尼罗河病毒感染
J Virol. 2021 Sep 9;95(19):e0061921. doi: 10.1128/JVI.00619-21.
7
Challenges of Vaccine Development for Zika Virus.寨卡病毒疫苗研发的挑战
Viral Immunol. 2018 Mar;31(2):117-123. doi: 10.1089/vim.2017.0145. Epub 2017 Dec 11.
8
Flavivirus proteases: The viral Achilles heel to prevent future pandemics.黄病毒蛋白酶:预防未来大流行的病毒阿喀琉斯之踵。
Antiviral Res. 2023 Feb;210:105516. doi: 10.1016/j.antiviral.2022.105516. Epub 2022 Dec 29.
9
Immune Response to Dengue and Zika.登革热和 Zika 病毒的免疫反应
Annu Rev Immunol. 2018 Apr 26;36:279-308. doi: 10.1146/annurev-immunol-042617-053142. Epub 2018 Jan 18.
10
Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus.快速应对新发传染病——针对寨卡病毒的合成 DNA 疫苗开发的经验教训。
Microbes Infect. 2018 Dec;20(11-12):676-684. doi: 10.1016/j.micinf.2018.03.001. Epub 2018 Mar 17.

引用本文的文献

1
An update on the ocular manifestations of dengue.登革热眼部表现的最新情况。
Taiwan J Ophthalmol. 2024 Jan 9;14(4):540-547. doi: 10.4103/tjo.TJO-D-23-00106. eCollection 2024 Oct-Dec.
2
Dengue Virus Infection: Immune Response and Therapeutic Targets.登革病毒感染:免疫反应与治疗靶点
Am J Trop Med Hyg. 2024 Nov 12;112(1):37-44. doi: 10.4269/ajtmh.23-0545. Print 2025 Jan 8.
3
Ubiquitination of NS1 Confers Differential Adaptation of Zika Virus in Mammalian Hosts and Mosquito Vectors.泛素化 NS1 赋予寨卡病毒在哺乳动物宿主和蚊虫媒介中的差异适应性。
Adv Sci (Weinh). 2024 Oct;11(39):e2408024. doi: 10.1002/advs.202408024. Epub 2024 Aug 19.
4
Ocular Manifestations of Flavivirus Infections.黄病毒感染的眼部表现
Pathogens. 2023 Dec 15;12(12):1457. doi: 10.3390/pathogens12121457.
5
Mosquito Salivary Proteins and Arbovirus Infection: From Viral Enhancers to Potential Targets for Vaccines.蚊子唾液蛋白与虫媒病毒感染:从病毒增强剂到疫苗的潜在靶点
Pathogens. 2023 Feb 23;12(3):371. doi: 10.3390/pathogens12030371.
6
Recent Insights Into the Molecular Mechanism of Toll-Like Receptor Response to Dengue Virus Infection.对Toll样受体对登革病毒感染反应分子机制的最新见解
Front Microbiol. 2021 Sep 16;12:744233. doi: 10.3389/fmicb.2021.744233. eCollection 2021.
7
The key amino acids of E protein involved in early flavivirus infection: viral entry.参与早期黄病毒感染的 E 蛋白关键氨基酸:病毒进入。
Virol J. 2021 Jul 3;18(1):136. doi: 10.1186/s12985-021-01611-2.
8
Flavivirus: From Structure to Therapeutics Development.黄病毒:从结构到治疗药物研发
Life (Basel). 2021 Jun 25;11(7):615. doi: 10.3390/life11070615.
9
Ocular manifestations of emerging viral diseases.新兴病毒病的眼部表现。
Eye (Lond). 2021 Apr;35(4):1117-1139. doi: 10.1038/s41433-020-01376-y. Epub 2021 Jan 29.
10
Tick-Borne Flaviviruses Depress AKT Activity during Acute Infection by Modulating AKT1/2.蜱传黄病毒通过调节 AKT1/2 来抑制急性感染期间的 AKT 活性。
Viruses. 2020 Sep 23;12(10):1059. doi: 10.3390/v12101059.